Clinical trials
Observational Adrenoleukodystrophy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetix Biotherapeutics Inc. | 3 |
| Children's Hospital of Philadelphia | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Fairview University Medical Center | 1 |
| NeuroVia, Inc. | 1 |
| Paul Szabolcs | 1 |
| SwanBio Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adrenoleukodystrophy | 11 |
| Leukodystrophy, Globoid Cell | 4 |
| Leukodystrophy, Metachromatic | 4 |
| Leukoencephalopathies | 3 |
| Mucopolysaccharidoses | 3 |
| Peroxisomal Disorders | 3 |
| Alexander Disease | 2 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| CADASIL | 2 |
| Canavan Disease | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.